Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06431295 · ClinicalTrials.gov registry record · NA
Evaluation of a Digital Visual Acuity Device vs. Standard Visual Acuity Measurements
A NA study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT06431295: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT06431295 is a NA study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06431295, a NA study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this research is to validate and determine the accuracy of the experimental device when measuring visual acuity versus our standard visual acuity measurements and to gather voice recordings of letters to help build a special system that recognizes spoken letters.
Interventions
- DEVICE FaceScan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2027-10-01 |
| Est. Completion | 2029-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06431295
The ClinicalTrials.gov registry entry for NCT06431295 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FaceScan is the first listed.
NCT06431295 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06431295 about?
NCT06431295 is a clinical study titled "Evaluation of a Digital Visual Acuity Device vs. Standard Visual Acuity Measurements". The purpose of this research is to validate and determine the accuracy of the experimental device when measuring visual acuity versus our standard visual acuity measurements and to gather voice recordings of letters to help build a special system that recognizes spoken letters.
What is the current status of trial NCT06431295?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2027-10-01. Estimated completion is 2029-06.
What interventions are being tested in trial NCT06431295?
The interventions under investigation include: FaceScan (DEVICE).
Who is sponsoring clinical trial NCT06431295?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.